share_log

立方制药(003020.SZ):盐酸哌甲酯缓释片2024年4月已完成现场检查,预计2025年能有审批结果

Cube Pharmaceuticals (003020.SZ): Onsite inspection of methylphenidate hydrochloride extended-release tablets was completed in April 2024, and approval results are expected in 2025

Gelonghui Finance ·  May 24 03:22

Gelonghui May 24 | Cube Pharmaceutical (003020.SZ) was surveyed by investors on May 23, 2024, on “The situation of methylphenidate hydrochloride extended-release tablets?” The company replied that methylphenidate hydrochloride sustained-release tablets are three-layer osmosis pump sustained-release tablets. The application was accepted in the fourth quarter of last year, on-site inspection was completed in April 2024, and approval results are expected in 2025.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment